<DOC>
	<DOCNO>NCT00904306</DOCNO>
	<brief_summary>The purpose study test feasibility preliminary efficacy 6-month chromium picolinate ( CrPic ) treatment trial binge eat disorder ( BED ) .</brief_summary>
	<brief_title>Binge Eating Chromium Study</brief_title>
	<detailed_description>Binge eating ( i.e. , consumption unusually large amount food sense loss control ) common problem serious public health implication large part due role obesity . Binge eat lead weight gain common overweight individual . Current treatment binge eat disorder ( BED ) inadequate , previous randomize treatment trial suffer high drop rate due adverse effect pharmacological agent . Chromium picolinate dietary supplement show reduce symptom depression appetite regulation problem patient atypical depression ; chromium picolinate also affect insulin regulation show improve glucose level patient type-2 diabetes . This pilot study evaluate effect chromium picolinate binge eating , mood , body weight , glucose regulation overweight individual BED .</detailed_description>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Picolinic acid</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<criteria>1 . Currently meet DSMIV criterion binge eat disorder ( BED ) ; 2 . Is able provide inform consent meet study visit requirement ; 3 . Is psychiatrically stable ( e.g. , current suicidal homicidal intent psychiatric condition require acute intervention ) . 1 . Body mass index ( BMI ) &lt; 24.9 kg/m^2 ( underweight normal weight ) â‰¥ 40 kg/m^2 ( severely obese ) ; 2 . Postmenopausal ; 3 . Age &lt; 18 &gt; 55 year ; 4 . Pregnant , plan become pregnant study period , lactate ; 5 . Current psychotropic medication use ; 6 . Current use insulin medication control glucose metabolism ; 7 . Current use medication know significantly influence appetite weight [ i.e. , overthecounter appetite suppressant contain phentermine sibutramine , atypical antipsychotic agent high weight gain liability ( olanzapine , risperidone , etc ) , prednisone , etc . ] ; 8 . Fasting glucose level &gt; 126 mg/dL ( indicative diabetes ) ; 9 . Creatinine level indicate renal insufficiency ( &gt; 1.0 woman ; &gt; 1.2 men ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>binge eat</keyword>
	<keyword>chromium</keyword>
	<keyword>mood</keyword>
	<keyword>glucose</keyword>
	<keyword>appetite</keyword>
</DOC>